CD8A and neoplasm: Antigen-specific CD4+ and CD8+ T cells in tumors are functionally exhausted and can be reinvigorated using immune checkpoint inhibitors which result in tumor destruction; however, efficient presentation of tumor antigens appears to be key to ICI efficacy [52].